Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria

American Journal of Gastroenterology

Volumn 105, Issue 12, 2010, Pages 2626-2631

  Xiao, Ying Lian ^a   Peng, Sui ^a   Tao, Jin ^a   Wang, An Jiang ^b   Lin, Jin Kun ^a   Hu, Pin Jin ^a   Chen, Min Hu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG SCREENING; DYSPEPSIA; EPIGASTRIC BURNING; EPIGASTRIC FULLNESS; EPIGASTRIC PAIN; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGIC ESOPHAGEAL ACID REFLUX; PH MEASUREMENT; POSTPRANDIAL STATE; PREVALENCE; PRIORITY JOURNAL; SATIETY; SENSITIVITY AND SPECIFICITY; SYMPTOM;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; DYSPEPSIA; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROTON PUMP INHIBITORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 78649877390     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.351     Document Type: Article

References (14)

1. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006;130: 1466-79.
2. Guillemot F, Ducrott éP, Bueno L. Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal refl ux disease in general practice. Gastroenterol Clin Biol 2005;29:243-6.
3. Jamieson JR, Stein HJ, DeMeester TR et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specifi city, sensitivity, and reproducibility. Am J Gastroenterol 1992;87: 1102-11.
4. Tack J, Caenepeel P, Arts J et al. Prevalence of acid refl ux in functional dyspepsia and its association with symptom profi le. Gut 2005;54: 1370-6.
5. Farup PG, Hovde O, Torp R et al. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal refl ux pattern. Scand J Gastroenterol 1999;34: 575-9.
6. Wang A, Liao X, Xiong L et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol 2008;8: 43.
7. Drossman DA, Corazziari E, Delvaux M et al. The functional gastrointestinal disorders. 3rd edn Degnon: Washington, 2006.
8. Veldhuyzen Van Zanten SJ, Talley NJ, Bytzer P et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45: II69-77.
9. Fass R, Ofman JJ, Sampliner RE et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal refl ux disease in symptomatic patients wiTherosive oesophagitis. Aliment Pharmacol Ther 2000;14: 389-96.
10. Martinez SD, Malagon IB, Garewal HS et al. Non-erosive refl ux disease (NERD)-acid refl ux and symptom patterns. Aliment Pharmacol Ther 2003;17: 537-45.
11. Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive refl ux disease: a unifying hypothesis. Gastroenterology 2005;128: 771-8.
12. Talley NJ, Meineche-Schmidt V, Par éP et al. Effi cacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the BOND and OPERA studies). Aliment Pharmacol Ther 1998;12: 1055-65.
13. Bolling-Sternevald E, Lauritsen K, Aalykke C et al. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebocontrolled trial. Scand J Gastroenterol 2002;37: 1395-402.
14. Wong WM, Wong BCY, Hung WK et al. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut 2002;51: 502-6.